This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.
in vitro toxicology

Nephrotoxicity

Find out more about our Chronic Exposure Nephrotoxicity Assay

It is estimated that drugs are responsible approximately 20% of acute renal failure episodes; this figure increases dramatically in the elderly where the incidence of drug-induced nephrotoxicity is reported to be as high as 66%1,2,3,4. This increased incidence in the elderly is thought to be a consequence of underlying conditions such as diabetes, cardiovascular disease and renal insufficiency as well as exposure to a greater number of co-administered drugs5.

The kidneys have a rich blood supply, have significant transporter activity and act as a highly structured filtration network. These features can result in the kidneys being exposed to high concentrations of drugs or metabolites, which ultimately increases their susceptibility to drug-induced toxicity6.

Due to the incidence of drug-induced nephrotoxicity, it is important to understand the risks of this liability prior to reaching the clinic. In vitro human cell-based kidney models using RPTECs (renal proximal tubule epithelial cells) are now becoming popular for early stage testing of nephrotoxicity. These are the predominant cells in the proximal kidney tubule, which is one of the main sites for reabsorption and drug accumulation.

Cyprotex offer a multiparametric high content screening (HCS) assay which evaluates the chronic exposure of test articles over 9 days and measures multiple relevant cell health markers including glutathione content (GSH), phospholipidosis (PLD), mitochondrial mass and mitochondrial membrane potential, as well as cellular ATP levels in a human kidney relevant in vitro cell-based model utilising RPTECs.

Find out more about our Chronic Exposure Nephrotoxicity Assay

References

1 Kaufman J et al., (1991) Community-acquired acute renal failure. Am J Kidney Dis 17(2): 191-198
2 Nash K et al., (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39(5): 930-936
3 Bellomo R (2006) The epidemiology of acute renal failure: 1975 versus 2005. Curr Opin Crit Care 12(6): 557-560
4 Kohli HS et al., (2000) Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant 15(2): 212-217
5 Naughton CA (2008) Drug-induced nephrotoxicity. Am Fam Physician 78(6): 743-750

 
Request a Quote
Speak to a Scientist
ADME-Tox Guides Pricing & Discounts

Contact us to discuss your ADME Tox issues or request a quote

Telephone:
North America (East Coast): 888-297-7683
Europe: +44 1625 505100

 

or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

Close